Precision Biosciences (DTIL) Operating Income (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172.55% |
| Dec 31, 2025 | 160.52% |
| Sep 30, 2025 | 5.53% |
| Jun 30, 2025 | 1.06% |
| Mar 31, 2025 | 11.00% |
| Dec 31, 2024 | -16.78% |
| Sep 30, 2024 | -188.11% |
| Jun 30, 2024 | 676.69% |
| Mar 31, 2024 | 71.88% |
| Dec 31, 2023 | -20.44% |
| Sep 30, 2023 | -295.11% |
| Jun 30, 2023 | 76.57% |
| Mar 31, 2023 | -10.28% |
| Dec 31, 2022 | 17.49% |
| Sep 30, 2022 | 50.34% |
| Jun 30, 2022 | -8.12% |
| Mar 31, 2022 | 11.03% |
| Dec 31, 2021 | -166.19% |
| Sep 30, 2021 | -153.36% |
| Jun 30, 2021 | 215.42% |
| Mar 31, 2021 | 20.18% |
| Dec 31, 2020 | 9.84% |
| Sep 30, 2020 | 20.62% |
| Jun 30, 2020 | -19.32% |
| Mar 31, 2020 | -25.78% |
| Dec 31, 2019 | 0.53% |
| Sep 30, 2019 | 7.93% |
| Jun 30, 2019 | -22.45% |
| Mar 31, 2019 | -21.04% |
| Dec 31, 2018 | -54.16% |
| Sep 30, 2018 | 13.84% |
| Jun 30, 2018 | -31.29% |